ID   TRIM5_HUMAN             Reviewed;         493 AA.
AC   Q9C035; A6NGQ1; A8WFA8; D3DQS8; D3DQS9; G3GJY1; Q2MLV4; Q2MLV8;
AC   Q2MLV9; Q2MLW1; Q2MLW3; Q2MLW4; Q2MLW6; Q2MLW7; Q2MLX1; Q2MLX2;
AC   Q2MLX3; Q2MLX5; Q2MLY3; Q2MLY4; Q2V6Q6; Q6GX26; Q8WU46; Q96SR5;
AC   Q9C031; Q9C032; Q9C033; Q9C034;
DT   28-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   10-MAY-2017, entry version 165.
DE   RecName: Full=Tripartite motif-containing protein 5;
DE            EC=2.3.2.27;
DE   AltName: Full=RING finger protein 88;
DE   AltName: Full=RING-type E3 ubiquitin transferase TRIM5 {ECO:0000305};
GN   Name=TRIM5; Synonyms=RNF88;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS ALPHA; BETA; GAMMA; DELTA AND
RP   EPSILON), AND VARIANT GLN-136.
RX   PubMed=11331580; DOI=10.1093/emboj/20.9.2140;
RA   Reymond A., Meroni G., Fantozzi A., Merla G., Cairo S., Luzi L.,
RA   Riganelli D., Zanaria E., Messali S., Cainarca S., Guffanti A.,
RA   Minucci S., Pelicci P.G., Ballabio A.;
RT   "The tripartite motif family identifies cell compartments.";
RL   EMBO J. 20:2140-2151(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ALPHA).
RX   PubMed=15249690; DOI=10.1073/pnas.0402876101;
RA   Yap M.W., Nisole S., Lynch C., Stoye J.P.;
RT   "Trim5alpha protein restricts both HIV-1 and murine leukemia virus.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:10786-10791(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM ALPHA), AND VARIANTS TYR-43
RP   AND ASP-249.
RX   PubMed=16401428; DOI=10.1016/j.cub.2005.11.045;
RA   Sawyer S.L., Wu L.I., Akey J.M., Emerman M., Malik H.S.;
RT   "High-frequency persistence of an impaired allele of the retroviral
RT   defense gene TRIM5alpha in humans.";
RL   Curr. Biol. 16:95-100(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], VARIANT GLN-136, FUNCTION,
RP   AUTOUBIQUITINATION, UBIQUITINATION BY TRIM21, AND MUTAGENESIS OF
RP   CYS-15.
RC   TISSUE=Brain;
RX   PubMed=18312418; DOI=10.1111/j.1742-4658.2008.06313.x;
RA   Yamauchi K., Wada K., Tanji K., Tanaka M., Kamitani T.;
RT   "Ubiquitination of E3 ubiquitin ligase TRIM5 alpha and its potential
RT   role.";
RL   FEBS J. 275:1540-1555(2008).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM EPSILON), ALTERNATIVE SPLICING,
RP   AND FUNCTION.
RX   PubMed=21632761; DOI=10.1128/JVI.00648-11;
RA   Battivelli E., Migraine J., Lecossier D., Matsuoka S.,
RA   Perez-Bercoff D., Saragosti S., Clavel F., Hance A.J.;
RT   "Modulation of TRIM5alpha activity in human cells by alternatively
RT   spliced TRIM5 isoforms.";
RL   J. Virol. 85:7828-7835(2011).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA), AND VARIANT
RP   GLN-136.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS SER-31; TYR-43;
RP   TYR-58; GLU-110; PHE-112; GLN-136; ASP-249; TYR-419; SER-467 AND
RP   LEU-479.
RG   NIEHS SNPs program;
RL   Submitted (NOV-2007) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM GAMMA).
RC   TISSUE=Rhabdomyosarcoma;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH BTBD1 AND BTBD2.
RX   PubMed=12878161; DOI=10.1016/S0014-4827(03)00187-3;
RA   Xu L., Yang L., Moitra P.K., Hashimoto K., Rallabhandi P., Kaul S.,
RA   Meroni G., Jensen J.P., Weissman A.M., D'Arpa P.;
RT   "BTBD1 and BTBD2 colocalize to cytoplasmic bodies with the
RT   RBCC/tripartite motif protein, TRIM5delta.";
RL   Exp. Cell Res. 288:84-93(2003).
RN   [12]
RP   FUNCTION (ISOFORM ALPHA).
RX   PubMed=16474118; DOI=10.1128/JVI.80.5.2100-2105.2006;
RA   Passerini L.D., Keckesova Z., Towers G.J.;
RT   "Retroviral restriction factors Fv1 and TRIM5alpha act independently
RT   and can compete for incoming virus before reverse transcription.";
RL   J. Virol. 80:2100-2105(2006).
RN   [13]
RP   MUTAGENESIS OF ARG-332.
RX   PubMed=16809279; DOI=10.1128/JVI.00270-06;
RA   Li Y., Li X., Stremlau M., Lee M., Sodroski J.;
RT   "Removal of arginine 332 allows human TRIM5alpha to bind human
RT   immunodeficiency virus capsids and to restrict infection.";
RL   J. Virol. 80:6738-6744(2006).
RN   [14]
RP   FUNCTION (ISOFORM ALPHA).
RX   PubMed=16643975; DOI=10.1016/j.virol.2006.03.015;
RA   Stremlau M., Song B., Javanbakht H., Perron M., Sodroski J.;
RT   "Cyclophilin A: an auxiliary but not necessary cofactor for TRIM5alpha
RT   restriction of HIV-1.";
RL   Virology 351:112-120(2006).
RN   [15]
RP   REVIEW.
RX   PubMed=16956947; DOI=10.1128/JVI.01519-06;
RA   Luban J.;
RT   "Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus
RT   type 1 infection.";
RL   J. Virol. 81:1054-1061(2007).
RN   [16]
RP   FUNCTION, SUBUNIT, AND INTERACTION WITH TRIM6 AND TRIM34.
RX   PubMed=17156811; DOI=10.1016/j.virol.2006.10.035;
RA   Li X., Gold B., O'hUigin C., Diaz-Griffero F., Song B., Si Z., Li Y.,
RA   Yuan W., Stremlau M., Mische C., Javanbakht H., Scally M., Winkler C.,
RA   Dean M., Sodroski J.;
RT   "Unique features of TRIM5alpha among closely related human TRIM family
RT   members.";
RL   Virology 360:419-433(2007).
RN   [17]
RP   INTERACTION WITH HSPA1A/B.
RX   PubMed=20053985; DOI=10.1074/jbc.M109.040618;
RA   Hwang C.Y., Holl J., Rajan D., Lee Y., Kim S., Um M., Kwon K.S.,
RA   Song B.;
RT   "Hsp70 interacts with the retroviral restriction factor TRIM5alpha and
RT   assists the folding of TRIM5alpha.";
RL   J. Biol. Chem. 285:7827-7837(2010).
RN   [18]
RP   INTERACTION WITH SQSTM1, AND SUBCELLULAR LOCATION.
RX   PubMed=20357094; DOI=10.1128/JVI.02412-09;
RA   O'Connor C., Pertel T., Gray S., Robia S.L., Bakowska J.C., Luban J.,
RA   Campbell E.M.;
RT   "p62/sequestosome-1 associates with and sustains the expression of
RT   retroviral restriction factor TRIM5alpha.";
RL   J. Virol. 84:5997-6006(2010).
RN   [19]
RP   REVIEW, AND PROTEASOMAL DEGRADATION.
RX   PubMed=21247355; DOI=10.1089/AID.2010.0367;
RA   Sastri J., Campbell E.M.;
RT   "Recent insights into the mechanism and consequences of TRIM5alpha
RT   retroviral restriction.";
RL   AIDS Res. Hum. Retroviruses 27:231-238(2011).
RN   [20]
RP   REVIEW.
RX   PubMed=21575904; DOI=10.1016/j.chom.2011.05.003;
RA   Tareen S.U., Emerman M.;
RT   "Trim5 TAKes on pattern recognition.";
RL   Cell Host Microbe 9:349-350(2011).
RN   [21]
RP   INTERACTION WITH TRIM6 AND TRIM34.
RX   PubMed=21680743; DOI=10.1074/jbc.M111.260406;
RA   Li X., Yeung D.F., Fiegen A.M., Sodroski J.;
RT   "Determinants of the higher order association of the restriction
RT   factor TRIM5alpha and other tripartite motif (TRIM) proteins.";
RL   J. Biol. Chem. 286:27959-27970(2011).
RN   [22]
RP   REVIEW.
RX   PubMed=21512569; DOI=10.1038/472305a;
RA   Aiken C., Joyce S.;
RT   "Immunology: TRIM5 does double duty.";
RL   Nature 472:305-306(2011).
RN   [23]
RP   FUNCTION, AND INTERACTION WITH MAP3K7/TAK1; TAB2 AND TAB3.
RX   PubMed=21512573; DOI=10.1038/nature09976;
RA   Pertel T., Hausmann S., Morger D., Zueger S., Guerra J., Lascano J.,
RA   Reinhard C., Santoni F.A., Uchil P.D., Chatel L., Bisiaux A.,
RA   Albert M.L., Strambio-De-Castillia C., Mothes W., Pizzato M.,
RA   Gruetter M.G., Luban J.;
RT   "TRIM5 is an innate immune sensor for the retrovirus capsid lattice.";
RL   Nature 472:361-365(2011).
RN   [24]
RP   REVIEW.
RX   PubMed=21572451; DOI=10.1038/nrmicro2582;
RA   Jermy A.;
RT   "Antiviral immunity: TRIM5 moonlights as a pattern recognition
RT   receptor.";
RL   Nat. Rev. Microbiol. 9:398-398(2011).
RN   [25]
RP   INTERACTION WITH PSMC2.
RX   PubMed=22078707; DOI=10.1186/1742-4690-8-93;
RA   Lukic Z., Hausmann S., Sebastian S., Rucci J., Sastri J., Robia S.L.,
RA   Luban J., Campbell E.M.;
RT   "TRIM5alpha associates with proteasomal subunits in cells while in
RT   complex with HIV-1 virions.";
RL   Retrovirology 8:93-93(2011).
RN   [26]
RP   FUNCTION.
RX   PubMed=21035162; DOI=10.1016/j.virol.2010.09.018;
RA   Tareen S.U., Emerman M.;
RT   "Human Trim5alpha has additional activities that are uncoupled from
RT   retroviral capsid recognition.";
RL   Virology 409:113-120(2011).
RN   [27]
RP   REVIEW.
RX   PubMed=21866272; DOI=10.3390/v3071204;
RA   de Silva S., Wu L.;
RT   "TRIM5 acts as more than a retroviral restriction factor.";
RL   Viruses 3:1204-1209(2011).
RN   [28]
RP   REVIEW.
RX   PubMed=22482711; DOI=10.1016/j.coviro.2012.02.003;
RA   Gruetter M.G., Luban J.;
RT   "TRIM5 structure, HIV-1 capsid recognition, and innate immune
RT   signaling.";
RL   Curr. Opin. Virol. 2:142-150(2012).
RN   [29]
RP   REVIEW, AND FUNCTION.
RX   PubMed=22291694; DOI=10.3389/fmicb.2012.00013;
RA   Nakayama E.E., Shioda T.;
RT   "TRIM5alpha and species tropism of HIV/SIV.";
RL   Front. Microbiol. 3:13-13(2012).
RN   [30]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [31]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-86, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [32]
RP   FUNCTION, INTERACTION WITH ULK1; SQSTM1; GABARAP; GABARAPL1;
RP   GABARAPL2; MAP1LC3A; MAP1LC3C AND BECN1, AND SUBCELLULAR LOCATION.
RX   PubMed=25127057; DOI=10.1016/j.devcel.2014.06.013;
RA   Mandell M.A., Jain A., Arko-Mensah J., Chauhan S., Kimura T.,
RA   Dinkins C., Silvestri G., Munch J., Kirchhoff F., Simonsen A., Wei Y.,
RA   Levine B., Johansen T., Deretic V.;
RT   "TRIM proteins regulate autophagy and can target autophagic substrates
RT   by direct recognition.";
RL   Dev. Cell 30:394-409(2014).
RN   [33]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [34]
RP   STRUCTURE BY NMR OF 1-78.
RX   PubMed=21734049; DOI=10.1128/JVI.00497-11;
RA   Lienlaf M., Hayashi F., Di Nunzio F., Tochio N., Kigawa T.,
RA   Yokoyama S., Diaz-Griffero F.;
RT   "Contribution of E3-ubiquitin ligase activity to HIV-1 restriction by
RT   TRIM5alpha(rh): structure of the RING domain of TRIM5alpha.";
RL   J. Virol. 85:8725-8737(2011).
RN   [35]
RP   STRUCTURE BY NMR OF 86-129.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the b-box domain from tripartite motif-
RT   containing protein 5.";
RL   Submitted (FEB-2009) to the PDB data bank.
CC   -!- FUNCTION: Capsid-specific restriction factor that prevents
CC       infection from non-host-adapted retroviruses. Blocks viral
CC       replication early in the life cycle, after viral entry but before
CC       reverse transcription. In addition to acting as a capsid-specific
CC       restriction factor, also acts as a pattern recognition receptor
CC       that activates innate immune signaling in response to the
CC       retroviral capsid lattice. Binding to the viral capsid triggers
CC       its E3 ubiquitin ligase activity, and in concert with the
CC       heterodimeric ubiquitin conjugating enzyme complex UBE2V1-UBE2N
CC       (also known as UBC13-UEV1A complex) generates 'Lys-63'-linked
CC       polyubiquitin chains, which in turn are catalysts in the
CC       autophosphorylation of the MAP3K7/TAK1 complex (includes TAK1,
CC       TAB2, and TAB3). Activation of the MAP3K7/TAK1 complex by
CC       autophosphorylation results in the induction and expression of NF-
CC       kappa-B and MAPK-responsive inflammatory genes, thereby leading to
CC       an innate immune response in the infected cell. Restricts
CC       infection by N-tropic murine leukemia virus (N-MLV), equine
CC       infectious anemia virus (EIAV), simian immunodeficiency virus of
CC       macaques (SIVmac), feline immunodeficiency virus (FIV), and bovine
CC       immunodeficiency virus (BIV) (PubMed:17156811). Plays a role in
CC       regulating autophagy through activation of autophagy regulator
CC       BECN1 by causing its dissociation from its inhibitors BCL2 and
CC       TAB2 (PubMed:25127057). Also plays a role in autophagy by acting
CC       as a selective autophagy receptor which recognizes and targets
CC       HIV-1 capsid protein p24 for autophagic destruction
CC       (PubMed:25127057). {ECO:0000269|PubMed:12878161,
CC       ECO:0000269|PubMed:17156811, ECO:0000269|PubMed:18312418,
CC       ECO:0000269|PubMed:21035162, ECO:0000269|PubMed:21512573,
CC       ECO:0000269|PubMed:21632761, ECO:0000269|PubMed:22291694,
CC       ECO:0000269|PubMed:25127057}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Can form homodimers and homotrimers. In addition to
CC       lower-order dimerization, also exhibits a higher-order
CC       multimerization and both low- and high-order multimerizations are
CC       essential for its restriction activity. Isoform Delta interacts
CC       with BTBD1 and BTBD2. Interacts with PSMC4, PSMC5, PSMD7 and
CC       HSPA8/HSC70 (By similarity). Interacts (via B30.2/SPRY domain)
CC       with HSPA1A/B. Interacts with PSMC2, MAP3K7/TAK1, TAB2 and TAB3
CC       (PubMed:21512573, PubMed:22078707). Interacts with SQSTM1
CC       (PubMed:20357094, PubMed:25127057). Interacts with TRIM6 and
CC       TRIM34 (PubMed:21680743, PubMed:17156811). Interacts with ULK1
CC       (phosphorylated form), GABARAP, GABARAPL1, GABARAPL2, MAP1LC3A,
CC       MAP1LC3C and BECN1 (PubMed:25127057). {ECO:0000250,
CC       ECO:0000269|PubMed:12878161, ECO:0000269|PubMed:17156811,
CC       ECO:0000269|PubMed:20053985, ECO:0000269|PubMed:20357094,
CC       ECO:0000269|PubMed:21512573, ECO:0000269|PubMed:21680743,
CC       ECO:0000269|PubMed:22078707, ECO:0000269|PubMed:25127057}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-924214, EBI-924214;
CC       Q2Y080:- (xeno); NbExp=3; IntAct=EBI-924230, EBI-924086;
CC       O95863:SNAI1; NbExp=3; IntAct=EBI-924214, EBI-1045459;
CC       Q13049:TRIM32; NbExp=2; IntAct=EBI-924214, EBI-742790;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:25127057}.
CC       Cytoplasm, P-body {ECO:0000269|PubMed:12878161,
CC       ECO:0000269|PubMed:20357094}. Nucleus
CC       {ECO:0000250|UniProtKB:Q0PF16}. Note=Predominantly cytoplasmic,
CC       and is only occasionally and partially localized in the nucleus
CC       (PubMed:25127057). Closely associates with proteasomal subunits in
CC       cytoplasmic bodies (By similarity). Colocalizes with SQSTM1 in
CC       cytoplasmic bodies (By similarity). {ECO:0000250|UniProtKB:Q0PF16,
CC       ECO:0000269|PubMed:25127057}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=Alpha;
CC         IsoId=Q9C035-1; Sequence=Displayed;
CC       Name=Beta;
CC         IsoId=Q9C035-2; Sequence=VSP_009010, VSP_009011;
CC         Note=Probable artifact.;
CC       Name=Gamma;
CC         IsoId=Q9C035-3; Sequence=VSP_009012, VSP_009013;
CC       Name=Delta;
CC         IsoId=Q9C035-4; Sequence=VSP_009014, VSP_009015;
CC       Name=Epsilon; Synonyms=Kappa;
CC         IsoId=Q9C035-5; Sequence=VSP_009016, VSP_009017;
CC       Name=Iota;
CC         IsoId=Q9C035-6; Sequence=VSP_044095, VSP_044096;
CC         Note=Has dominant-negative activity against TRIM5alpha. Does not
CC         inhibit HIV-1 replication.;
CC   -!- DOMAIN: The B box-type zinc finger domain and the coiled-coil
CC       domain contribute to the higher and low order multimerization
CC       respectively which is essential for restriction activity
CC       (PubMed:22482711). The coiled coil domain is important for higher
CC       order multimerization by promoting the initial dimerization (By
CC       similarity). {ECO:0000250|UniProtKB:Q0PF16,
CC       ECO:0000269|PubMed:22482711}.
CC   -!- DOMAIN: The B30.2/SPRY domain acts as a capsid recognition domain.
CC       Polymorphisms in this domain explain the observed species-specific
CC       differences among orthologs (PubMed:22482711).
CC       {ECO:0000269|PubMed:22482711}.
CC   -!- DOMAIN: The RING-type zinc finger domain confers E3 ubiquitin
CC       ligase activity and is essential for retrovirus restriction
CC       activity, autoubiquitination and higher-order multimerization.
CC       {ECO:0000269|PubMed:22482711}.
CC   -!- PTM: Degraded in a proteasome-independent fashion in the absence
CC       of viral infection but in a proteasome-dependent fashion following
CC       exposure to restriction sensitive virus.
CC   -!- PTM: Autoubiquitinated in a RING finger- and UBE2D2-dependent
CC       manner. Monoubiquitinated by TRIM21. Deubiquitinated by Yersinia
CC       YopJ. Ubiquitination may not lead to proteasomal degradation.
CC       {ECO:0000269|PubMed:18312418}.
CC   -!- SIMILARITY: Belongs to the TRIM/RBCC family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/trim5/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF220025; AAG53479.1; -; mRNA.
DR   EMBL; AF220026; AAG53480.1; -; mRNA.
DR   EMBL; AF220027; AAG53481.1; -; mRNA.
DR   EMBL; AF220028; AAG53482.1; -; mRNA.
DR   EMBL; AF220029; AAG53483.1; -; mRNA.
DR   EMBL; AY625000; AAT48101.1; -; mRNA.
DR   EMBL; DQ301444; ABC00997.1; -; Genomic_DNA.
DR   EMBL; DQ301445; ABC00998.1; -; Genomic_DNA.
DR   EMBL; DQ301446; ABC00999.1; -; Genomic_DNA.
DR   EMBL; DQ301447; ABC01000.1; -; Genomic_DNA.
DR   EMBL; DQ301448; ABC01001.1; -; Genomic_DNA.
DR   EMBL; DQ301449; ABC01002.1; -; Genomic_DNA.
DR   EMBL; DQ301450; ABC01003.1; -; Genomic_DNA.
DR   EMBL; DQ301451; ABC01004.1; -; Genomic_DNA.
DR   EMBL; DQ301452; ABC01005.1; -; Genomic_DNA.
DR   EMBL; DQ301453; ABC01006.1; -; Genomic_DNA.
DR   EMBL; DQ301454; ABC01007.1; -; Genomic_DNA.
DR   EMBL; DQ301455; ABC01008.1; -; Genomic_DNA.
DR   EMBL; DQ301456; ABC01009.1; -; Genomic_DNA.
DR   EMBL; DQ301457; ABC01010.1; -; Genomic_DNA.
DR   EMBL; DQ301458; ABC01011.1; -; Genomic_DNA.
DR   EMBL; DQ301459; ABC01012.1; -; Genomic_DNA.
DR   EMBL; DQ301460; ABC01013.1; -; Genomic_DNA.
DR   EMBL; DQ301461; ABC01014.1; -; Genomic_DNA.
DR   EMBL; DQ301462; ABC01015.1; -; Genomic_DNA.
DR   EMBL; DQ301463; ABC01016.1; -; Genomic_DNA.
DR   EMBL; DQ301464; ABC01017.1; -; Genomic_DNA.
DR   EMBL; DQ301465; ABC01018.1; -; Genomic_DNA.
DR   EMBL; DQ301466; ABC01019.1; -; Genomic_DNA.
DR   EMBL; DQ301467; ABC01020.1; -; Genomic_DNA.
DR   EMBL; DQ301468; ABC01021.1; -; Genomic_DNA.
DR   EMBL; DQ301469; ABC01022.1; -; Genomic_DNA.
DR   EMBL; DQ301470; ABC01023.1; -; Genomic_DNA.
DR   EMBL; DQ301471; ABC01024.1; -; Genomic_DNA.
DR   EMBL; DQ301472; ABC01025.1; -; Genomic_DNA.
DR   EMBL; DQ301473; ABC01026.1; -; Genomic_DNA.
DR   EMBL; DQ301474; ABC01027.1; -; Genomic_DNA.
DR   EMBL; DQ301475; ABC01028.1; -; Genomic_DNA.
DR   EMBL; DQ301476; ABC01029.1; -; Genomic_DNA.
DR   EMBL; DQ301477; ABC01030.1; -; Genomic_DNA.
DR   EMBL; DQ301478; ABC01031.1; -; Genomic_DNA.
DR   EMBL; DQ301479; ABC01032.1; -; Genomic_DNA.
DR   EMBL; DQ301480; ABC01033.1; -; Genomic_DNA.
DR   EMBL; DQ288685; ABB90543.1; -; mRNA.
DR   EMBL; JF928461; AEN14475.1; -; mRNA.
DR   EMBL; JF928462; AEN14476.1; -; mRNA.
DR   EMBL; AK027593; BAB55218.1; -; mRNA.
DR   EMBL; AC015691; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471064; EAW68771.1; -; Genomic_DNA.
DR   EMBL; CH471064; EAW68772.1; -; Genomic_DNA.
DR   EMBL; CH471064; EAW68774.1; -; Genomic_DNA.
DR   EMBL; CH471064; EAW68775.1; -; Genomic_DNA.
DR   EMBL; EU260465; ABW96352.1; -; Genomic_DNA.
DR   EMBL; CH471064; EAW68776.1; -; Genomic_DNA.
DR   EMBL; CH471064; EAW68777.1; -; Genomic_DNA.
DR   EMBL; BC021258; AAH21258.1; -; mRNA.
DR   CCDS; CCDS31392.1; -. [Q9C035-4]
DR   CCDS; CCDS31393.1; -. [Q9C035-1]
DR   CCDS; CCDS31394.1; -. [Q9C035-3]
DR   RefSeq; NP_149023.2; NM_033034.2. [Q9C035-1]
DR   RefSeq; NP_149083.2; NM_033092.2. [Q9C035-3]
DR   RefSeq; NP_149084.2; NM_033093.2. [Q9C035-4]
DR   RefSeq; XP_005253240.1; XM_005253183.2. [Q9C035-1]
DR   RefSeq; XP_005253241.1; XM_005253184.2. [Q9C035-4]
DR   RefSeq; XP_011518729.1; XM_011520427.1. [Q9C035-5]
DR   UniGene; Hs.125300; -.
DR   PDB; 2ECV; NMR; -; A=1-78.
DR   PDB; 2YRG; NMR; -; A=86-129.
DR   PDBsum; 2ECV; -.
DR   PDBsum; 2YRG; -.
DR   ProteinModelPortal; Q9C035; -.
DR   SMR; Q9C035; -.
DR   BioGrid; 124491; 53.
DR   IntAct; Q9C035; 29.
DR   MINT; MINT-6631391; -.
DR   STRING; 9606.ENSP00000369373; -.
DR   iPTMnet; Q9C035; -.
DR   PhosphoSitePlus; Q9C035; -.
DR   BioMuta; TRIM5; -.
DR   DMDM; 38605459; -.
DR   EPD; Q9C035; -.
DR   MaxQB; Q9C035; -.
DR   PaxDb; Q9C035; -.
DR   PeptideAtlas; Q9C035; -.
DR   PRIDE; Q9C035; -.
DR   DNASU; 85363; -.
DR   Ensembl; ENST00000380027; ENSP00000369366; ENSG00000132256. [Q9C035-4]
DR   Ensembl; ENST00000380034; ENSP00000369373; ENSG00000132256. [Q9C035-1]
DR   Ensembl; ENST00000396847; ENSP00000380058; ENSG00000132256. [Q9C035-3]
DR   Ensembl; ENST00000433961; ENSP00000393052; ENSG00000132256. [Q9C035-5]
DR   GeneID; 85363; -.
DR   KEGG; hsa:85363; -.
DR   UCSC; uc001mbm.3; human. [Q9C035-1]
DR   CTD; 85363; -.
DR   DisGeNET; 85363; -.
DR   GeneCards; TRIM5; -.
DR   H-InvDB; HIX0009393; -.
DR   HGNC; HGNC:16276; TRIM5.
DR   HPA; CAB013497; -.
DR   HPA; HPA023420; -.
DR   HPA; HPA023422; -.
DR   MIM; 608487; gene.
DR   neXtProt; NX_Q9C035; -.
DR   OpenTargets; ENSG00000132256; -.
DR   PharmGKB; PA38109; -.
DR   eggNOG; ENOG410ITG7; Eukaryota.
DR   eggNOG; ENOG410XWDC; LUCA.
DR   GeneTree; ENSGT00760000118893; -.
DR   HOVERGEN; HBG001357; -.
DR   InParanoid; Q9C035; -.
DR   KO; K10648; -.
DR   OMA; NENYQPK; -.
DR   OrthoDB; EOG091G04O8; -.
DR   PhylomeDB; Q9C035; -.
DR   TreeFam; TF338674; -.
DR   BRENDA; 2.3.2.B10; 2681.
DR   BRENDA; 6.3.2.19; 2681.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; TRIM5; human.
DR   EvolutionaryTrace; Q9C035; -.
DR   GeneWiki; TRIM5alpha; -.
DR   GenomeRNAi; 85363; -.
DR   PRO; PR:Q9C035; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000132256; -.
DR   ExpressionAtlas; Q9C035; baseline and differential.
DR   Genevisible; Q9C035; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0000932; C:P-body; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0030674; F:protein binding, bridging; IPI:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0008329; F:signaling pattern recognition receptor activity; IDA:UniProtKB.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0002218; P:activation of innate immune response; IDA:UniProtKB.
DR   GO; GO:0006914; P:autophagy; IDA:UniProtKB.
DR   GO; GO:0051607; P:defense response to virus; TAS:UniProtKB.
DR   GO; GO:0045087; P:innate immune response; IDA:UniProtKB.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0046597; P:negative regulation of viral entry into host cell; IDA:UniProtKB.
DR   GO; GO:1902187; P:negative regulation of viral release from host cell; IDA:UniProtKB.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; IMP:UniProtKB.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:UniProtKB.
DR   GO; GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IMP:UniProtKB.
DR   GO; GO:0070534; P:protein K63-linked ubiquitination; IDA:UniProtKB.
DR   GO; GO:0070206; P:protein trimerization; IDA:UniProtKB.
DR   GO; GO:0031664; P:regulation of lipopolysaccharide-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0032880; P:regulation of protein localization; IMP:UniProtKB.
DR   CDD; cd00162; RING; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR001870; B30.2/SPRY.
DR   InterPro; IPR003879; Butyrophylin.
DR   InterPro; IPR013320; ConA-like_dom.
DR   InterPro; IPR003877; SPRY_dom.
DR   InterPro; IPR032917; TRIM5.
DR   InterPro; IPR027370; Znf-RING_LisH.
DR   InterPro; IPR000315; Znf_B-box.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   PANTHER; PTHR24103:SF426; PTHR24103:SF426; 1.
DR   Pfam; PF00622; SPRY; 1.
DR   Pfam; PF00643; zf-B_box; 1.
DR   Pfam; PF13445; zf-RING_UBOX; 1.
DR   PRINTS; PR01407; BUTYPHLNCDUF.
DR   SMART; SM00336; BBOX; 1.
DR   SMART; SM00184; RING; 1.
DR   SMART; SM00449; SPRY; 1.
DR   SUPFAM; SSF49899; SSF49899; 1.
DR   PROSITE; PS50188; B302_SPRY; 1.
DR   PROSITE; PS50119; ZF_BBOX; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Antiviral defense;
KW   Autophagy; Coiled coil; Complete proteome; Cytoplasm;
KW   Host-virus interaction; Immunity; Innate immunity; Metal-binding;
KW   Nucleus; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transferase; Ubl conjugation; Ubl conjugation pathway; Zinc;
KW   Zinc-finger.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22223895}.
FT   CHAIN         2    493       Tripartite motif-containing protein 5.
FT                                /FTId=PRO_0000056201.
FT   DOMAIN      281    493       B30.2/SPRY. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00548}.
FT   ZN_FING      15     59       RING-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00175}.
FT   ZN_FING      90    132       B box-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00024}.
FT   REGION      185    198       Required for interaction with GABARAP and
FT                                for autophagy.
FT                                {ECO:0000250|UniProtKB:Q0PF16}.
FT   COILED      130    241       {ECO:0000255}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:22223895}.
FT   MOD_RES      86     86       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     249    271       GVDGVIKRTENVTLKKPETFPKN -> DGERDLEEARNFSK
FT                                KSKESVSSS (in isoform Epsilon).
FT                                {ECO:0000303|PubMed:11331580,
FT                                ECO:0000303|PubMed:21632761}.
FT                                /FTId=VSP_009016.
FT   VAR_SEQ     249    257       GVDGVIKRT -> VKSGKKPEH (in isoform Iota).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_044095.
FT   VAR_SEQ     258    493       Missing (in isoform Iota). {ECO:0000305}.
FT                                /FTId=VSP_044096.
FT   VAR_SEQ     272    493       Missing (in isoform Epsilon).
FT                                {ECO:0000303|PubMed:11331580,
FT                                ECO:0000303|PubMed:21632761}.
FT                                /FTId=VSP_009017.
FT   VAR_SEQ     299    347       VDVTVAPNNISCAVISEDKRQVSSPKPQIIYGARGTRYQTF
FT                                VNFNYCTG -> GKEKSHYHKPPCGLSLLLSLSFRILCSLL
FT                                GSCFKIYDSPSKTHITYPSL (in isoform Gamma).
FT                                {ECO:0000303|PubMed:11331580,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_009012.
FT   VAR_SEQ     299    326       VDVTVAPNNISCAVISEDKRQVSSPKPQ -> GWSAMARSR
FT                                FTATSTSQIQAILLPQPPK (in isoform Delta).
FT                                {ECO:0000303|PubMed:11331580}.
FT                                /FTId=VSP_009014.
FT   VAR_SEQ     327    493       Missing (in isoform Delta).
FT                                {ECO:0000303|PubMed:11331580}.
FT                                /FTId=VSP_009015.
FT   VAR_SEQ     348    493       Missing (in isoform Gamma).
FT                                {ECO:0000303|PubMed:11331580,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_009013.
FT   VAR_SEQ     390    400       NENYQPKYGYW -> KRFMILLPRHT (in isoform
FT                                Beta). {ECO:0000303|PubMed:11331580}.
FT                                /FTId=VSP_009010.
FT   VAR_SEQ     401    493       Missing (in isoform Beta).
FT                                {ECO:0000303|PubMed:11331580}.
FT                                /FTId=VSP_009011.
FT   VARIANT      31     31       G -> S (in dbSNP:rs59896509).
FT                                {ECO:0000269|Ref.9}.
FT                                /FTId=VAR_060707.
FT   VARIANT      43     43       H -> Y (in dbSNP:rs3740996).
FT                                {ECO:0000269|PubMed:16401428,
FT                                ECO:0000269|Ref.9}.
FT                                /FTId=VAR_017397.
FT   VARIANT      58     58       C -> Y (in dbSNP:rs61432120).
FT                                {ECO:0000269|Ref.9}.
FT                                /FTId=VAR_060708.
FT   VARIANT     110    110       G -> E (in dbSNP:rs56348930).
FT                                {ECO:0000269|Ref.9}.
FT                                /FTId=VAR_060709.
FT   VARIANT     112    112       V -> F (in dbSNP:rs11601507).
FT                                {ECO:0000269|Ref.9}.
FT                                /FTId=VAR_030154.
FT   VARIANT     136    136       R -> Q (in dbSNP:rs10838525).
FT                                {ECO:0000269|PubMed:11331580,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:18312418,
FT                                ECO:0000269|Ref.9}.
FT                                /FTId=VAR_017398.
FT   VARIANT     249    249       G -> D (in dbSNP:rs11038628).
FT                                {ECO:0000269|PubMed:16401428,
FT                                ECO:0000269|Ref.9}.
FT                                /FTId=VAR_030155.
FT   VARIANT     419    419       H -> Y (in dbSNP:rs28381981).
FT                                {ECO:0000269|Ref.9}.
FT                                /FTId=VAR_030156.
FT   VARIANT     467    467       C -> S (in dbSNP:rs59218593).
FT                                {ECO:0000269|Ref.9}.
FT                                /FTId=VAR_060710.
FT   VARIANT     479    479       P -> L (in dbSNP:rs7104422).
FT                                {ECO:0000269|Ref.9}.
FT                                /FTId=VAR_030157.
FT   MUTAGEN      15     15       C->A: Abolishes E3 ligase activity.
FT                                {ECO:0000269|PubMed:18312418}.
FT   MUTAGEN     332    332       R->A,G,H,P,Q,S: Increases strongly cell
FT                                restriction against HIV-1 and SIVmac
FT                                infection. {ECO:0000269|PubMed:16809279}.
FT   MUTAGEN     332    332       R->D,E,L: Increases strongly cell
FT                                restriction against HIV-1 infection.
FT                                {ECO:0000269|PubMed:16809279}.
FT   MUTAGEN     332    332       R->K: No effect on HIV-1 and SIVmac
FT                                infection. {ECO:0000269|PubMed:16809279}.
FT   CONFLICT     76     76       I -> L (in Ref. 2; BAB55218).
FT                                {ECO:0000305}.
FT   CONFLICT    130    130       L -> P (in Ref. 2; BAB55218).
FT                                {ECO:0000305}.
FT   TURN         16     18       {ECO:0000244|PDB:2ECV}.
FT   STRAND       29     31       {ECO:0000244|PDB:2ECV}.
FT   HELIX        38     45       {ECO:0000244|PDB:2ECV}.
FT   TURN         46     50       {ECO:0000244|PDB:2ECV}.
FT   TURN         56     58       {ECO:0000244|PDB:2ECV}.
FT   STRAND       64     66       {ECO:0000244|PDB:2ECV}.
FT   STRAND       92     94       {ECO:0000244|PDB:2YRG}.
FT   TURN         96     98       {ECO:0000244|PDB:2YRG}.
FT   STRAND      104    106       {ECO:0000244|PDB:2YRG}.
FT   TURN        107    109       {ECO:0000244|PDB:2YRG}.
FT   STRAND      111    113       {ECO:0000244|PDB:2YRG}.
FT   HELIX       115    118       {ECO:0000244|PDB:2YRG}.
FT   TURN        121    125       {ECO:0000244|PDB:2YRG}.
SQ   SEQUENCE   493 AA;  56338 MW;  8E61AAFD508AF6C0 CRC64;
     MASGILVNVK EEVTCPICLE LLTQPLSLDC GHSFCQACLT ANHKKSMLDK GESSCPVCRI
     SYQPENIRPN RHVANIVEKL REVKLSPEGQ KVDHCARHGE KLLLFCQEDG KVICWLCERS
     QEHRGHHTFL TEEVAREYQV KLQAALEMLR QKQQEAEELE ADIREEKASW KTQIQYDKTN
     VLADFEQLRD ILDWEESNEL QNLEKEEEDI LKSLTNSETE MVQQTQSLRE LISDLEHRLQ
     GSVMELLQGV DGVIKRTENV TLKKPETFPK NQRRVFRAPD LKGMLEVFRE LTDVRRYWVD
     VTVAPNNISC AVISEDKRQV SSPKPQIIYG ARGTRYQTFV NFNYCTGILG SQSITSGKHY
     WEVDVSKKTA WILGVCAGFQ PDAMCNIEKN ENYQPKYGYW VIGLEEGVKC SAFQDSSFHT
     PSVPFIVPLS VIICPDRVGV FLDYEACTVS FFNITNHGFL IYKFSHCSFS QPVFPYLNPR
     KCGVPMTLCS PSS
//
